{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:21:08Z","timestamp":1791422468622,"version":"4.3.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T00:00:00Z","timestamp":1286755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10787-010-0060-6","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T13:42:23Z","timestamp":1286977343000},"page":"75-87","source":"Crossref","is-referenced-by-count":48,"title":["Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase"],"prefix":"10.1007","volume":"19","author":[{"given":"Leo R.","family":"Fitzpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Frauenhoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn W.","family":"Maines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Upson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Mosher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,11]]},"reference":[{"key":"60_CR1","first-page":"240","volume":"17","author":"DD Anthony","year":"1999","unstructured":"Anthony DD, Haqqi TM (1999) Collagen-induced arthritis in mice: an animal model to study the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 17:240\u2013244","journal-title":"Clin Exp Rheumatol"},{"key":"60_CR2","first-page":"114","volume":"55","author":"DD Brand","year":"2005","unstructured":"Brand DD (2005) Rodent models of rheumatoid arthritis. Comp Med 55:114\u2013122","journal-title":"Comp Med"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1517\/14656560903071043","volume":"10","author":"MG Feely","year":"2009","unstructured":"Feely MG, Erickson A, O\u2019Dell JR (2009) Therapeutic options for rheumatoid arthritis. Expert Opin Pharmacother 10:2095\u20132106","journal-title":"Expert Opin Pharmacother"},{"key":"60_CR4","first-page":"5962","volume":"63","author":"KJ French","year":"2003","unstructured":"French KJ, Schrecengost B, Lee BD et al (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962\u20135969","journal-title":"Cancer Res"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1124\/jpet.106.101345","volume":"318","author":"KJ French","year":"2006","unstructured":"French KJ, Upson JJ, Keller SN et al (2006) Antitumor activity of sphingosine kinase inhibitors. JPET 318:596\u2013603","journal-title":"JPET"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.109.163444","volume":"333","author":"KJ French","year":"2010","unstructured":"French KJ, Zhuang Y, Maines LW et al (2010) Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. JPET 333:129\u2013139","journal-title":"JPET"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03008209909005273","volume":"40","author":"MB Goldring","year":"1999","unstructured":"Goldring MB (1999) The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40:1\u201311","journal-title":"Connect Tissue Res"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1073\/pnas.92.2.517","volume":"92","author":"RJ Griffiths","year":"1995","unstructured":"Griffiths RJ, Pettipher ER, Koch K et al (1995) Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA 92:517\u2013521","journal-title":"Proc Natl Acad Sci USA"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-2478(97)00040-0","volume":"58","author":"R Gugasyan","year":"1997","unstructured":"Gugasyan R, Clouston D, Mandel T et al (1997) Prevention of splenic granuloma formation in adjuvant arthritis by n2-acetyl-4-tetrahydroxybutylimidazole (THI). Immunol Lett 58:133\u2013138","journal-title":"Immunol Lett"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjp.0703751","volume":"131","author":"T Hamada","year":"2000","unstructured":"Hamada T, Arima N, Shindo M et al (2000) Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase inhibitor. Br J Pharmacol 131:1513\u20131520","journal-title":"Br J Pharmacol"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1084\/jem.20030016","volume":"197","author":"M Hegen","year":"2003","unstructured":"Hegen M, Sun L, Uozumi N et al (2003) Cytosolic phospholipase A2 alpha-deficient mice are resistant to collagen-induced arthritis. J Exp Med 197:1297\u20131302","journal-title":"J Exp Med"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/ard.2007.076430","volume":"67","author":"M Hegen","year":"2008","unstructured":"Hegen M, Keith JC, Collins M et al (2008) Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 67:1505\u20131515","journal-title":"Ann Rheum Dis"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0047-6374(01)00371-2","volume":"1","author":"R Holmdahl","year":"2002","unstructured":"Holmdahl R, Bockerman R, Bavklund J et al (2002) The molecular pathogenesis of collagen-induced arthritis in mice-a model for rheumatoid arthritis. Ageing Res Rev 1:135\u2013147","journal-title":"Ageing Res Rev"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pathophys.2005.07.011","volume":"12","author":"K Kannan","year":"2005","unstructured":"Kannan K, Otrmann RA, Kimpl D (2005) Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 12:167\u2013181","journal-title":"Pathophysiology"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1124\/jpet.102.040659","volume":"303","author":"S Kato","year":"2002","unstructured":"Kato S, Ogawa Y, Kanatu K et al (2002) Ulcerogenic influence of selective cyclooxygenase inhibitors in the rat stomach with adjuvant-induced arthritis. JPET 303:503\u2013509","journal-title":"JPET"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1440-1681.2005.04166.x","volume":"32","author":"TH Kee","year":"2005","unstructured":"Kee TH, Vit P, Melendez AJ (2005) Sphingosine kinase in immune cells. Clin Exp Pharmacol Physiol 32:153\u2013161","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"52487","DOI":"10.1074\/jbc.M406512200","volume":"279","author":"CA Keohane","year":"2004","unstructured":"Keohane CA, Mandala S, Spiegel S et al (2004) Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 279:52487\u201352492","journal-title":"J Biol Chem"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.4049\/jimmunol.181.11.8010","volume":"181","author":"WQ Lai","year":"2008","unstructured":"Lai WQ, Irwan AW, Goh HH et al (2008) Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 181:8010\u20138017","journal-title":"J Immunol"},{"key":"60_CR19","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.4049\/jimmunol.0804376","volume":"183","author":"WQ Lai","year":"2009","unstructured":"Lai WQ, Irwan AW, Goh HH (2009) Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis. J Immunol 183:2097\u20132103","journal-title":"J Immunol"},{"key":"60_CR20","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/art.10328","volume":"46","author":"JA Luross","year":"2002","unstructured":"Luross JA, Heaton T, Hirst TR et al (2002) Escherichia coli heat- labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells. Arthritis Rheum 46:1671\u20131682","journal-title":"Arthritis Rheum"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.169.11.6394","volume":"169","author":"AC MacKinnon","year":"2002","unstructured":"MacKinnon AC, Buckley A, Chilvers ER et al (2002) Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol 169:6394\u20136400","journal-title":"J Immunol"},{"key":"60_CR22","first-page":"2193","volume":"30","author":"K Magari","year":"2003","unstructured":"Magari K, Miyata S, Fusako N et al (2003) Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis. J Rheumatol 30:2193\u20132200","journal-title":"J Rheumatol"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1167\/iovs.05-1236","volume":"47","author":"LW Maines","year":"2006","unstructured":"Maines LW, French KJ, Wolpert EB et al (2006) Pharmacological manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases. Invest Opthamol Vis Sci 47:5022\u20135031","journal-title":"Invest Opthamol Vis Sci"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10620-007-0133-6","volume":"53","author":"LW Maines","year":"2008","unstructured":"Maines LW, Fitzpatrick LR, French KJ et al (2008) Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig Dis Sci 53:997\u20131012","journal-title":"Dig Dis Sci"},{"key":"60_CR25","doi-asserted-by":"crossref","unstructured":"Maines LW, Fitzpatrick LR, Green CL et al (2010) Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn\u2019s disease. Inflammopharmacology [PMID:2015210]","DOI":"10.1007\/s10787-010-0032-x"},{"issue":"Suppl 3","key":"60_CR26","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1007\/s000110050304","volume":"47","author":"A Matsukawa","year":"1998","unstructured":"Matsukawa A, Yoshinaga M (1998) Sequential generation of cytokines during the initiative phase of inflammation, with reference to neutrophils. Inflamm Res 47(Suppl 3):S137\u2013S144","journal-title":"Inflamm Res"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1016\/j.febslet.2006.07.035","volume":"580","author":"J Michaud","year":"2006","unstructured":"Michaud J, Kohno M, Proia RL et al (2006) Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett 580:4607\u20134612","journal-title":"FEBS Lett"},{"key":"60_CR28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.bjp.0704511","volume":"135","author":"T Ochi","year":"2002","unstructured":"Ochi T, Goto T (2002) Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. Br J Pharmacol 135:782\u2013788","journal-title":"Br J Pharmacol"},{"issue":"Suppl 4","key":"60_CR29","first-page":"56","volume":"23","author":"SJ Oliver","year":"1996","unstructured":"Oliver SJ, Brain E (1996) Combination therapy in rheumatoid arthritis: the animal model perspective. J Rheumatol 23(Suppl 4):56\u201360","journal-title":"J Rheumatol"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0090-6980(01)00108-3","volume":"64","author":"A Olivera","year":"2001","unstructured":"Olivera A, Spiegel S (2001) Sphingosine kinase: a mediator of vital cellular functions. Prostaglandins Other Lipid Mediat 64:123\u2013134","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0022-3565(25)38274-1","volume":"265","author":"CE Pendley","year":"1993","unstructured":"Pendley CE, Fitzpatrick LR, Ewing RW et al (1993) The gastrin\/cholecystokinin-B receptor antagonist reduces basal acid secretion and prevents gastrointestinal damage by aspirin, ethanol and cysteamine in the rat. JPET 265:1348\u20131354","journal-title":"JPET"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1096\/fj.02-1038com","volume":"17","author":"BJ Pettus","year":"2003","unstructured":"Pettus BJ, Bielawski J, Porcelli AM et al (2003) The sphingosine kinase 1\/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. Faseb J 17:1411\u20131421","journal-title":"Faseb J"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.22495","volume":"56","author":"H Saito","year":"2007","unstructured":"Saito H, Kojima T, Takahashi M et al (2007) A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as antitumor-necrosis factor-monoclonal antibody in murine collagen-induced arthritis. Arthritis Rheum 56:1164\u20131174","journal-title":"Arthritis Rheum"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7643-7520-1_1","volume-title":"in vivo models of inflammation","author":"LR Schopf","year":"2006","unstructured":"Schopf LR, Anderson K, Jeffee BD (2006) Rat models of arthritis: similarities, differences, advantages and disadvantages in the identification of novel therapeutics. In: Stevenson CS, Marshall LA, Morgan DW (eds) in vivo models of inflammation, vol 1. Birkhauser Verlag, Boston, USA, pp 1\u201334"},{"key":"60_CR35","unstructured":"Smith CD, French KJ, Zhuang Y (2008) Sphingosine kinase inhibitors. US Patent Number 7,338,961"},{"key":"60_CR36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5483\/BMBRep.2006.39.2.113","volume":"39","author":"TA Taha","year":"2006","unstructured":"Taha TA, Hannun YA, Obedi LM (2006) Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Bio 39:113\u2013131","journal-title":"J Biochem Mol Bio"},{"key":"60_CR37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"JAM Wessels","year":"2008","unstructured":"Wessels JAM, Huizings TWJ, Guchelaar HJ (2008) Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology 47:249\u2013255","journal-title":"Rheumatology"},{"key":"60_CR38","doi-asserted-by":"crossref","first-page":"14196","DOI":"10.1073\/pnas.95.24.14196","volume":"95","author":"P Xia","year":"1998","unstructured":"Xia P, Gamble JR, Trye KA et al (1998) Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci USA 95:14196\u201314201","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-010-0060-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-010-0060-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-010-0060-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T18:23:51Z","timestamp":1740594231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-010-0060-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s10787-010-0060-6","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,11]]}}}